Microbial-Derived Anti-Cancer Compounds: Advances in Drug Discovery, Bioengineering, and Therapeutic Applications
Future directions should focus on integrating AI with synthetic biology to engineer microbial strains capable of producing enhanced bioactive compounds. Additionally, leveraging nanotechnology could refine targeted delivery mechanisms. A deeper understanding of molecular pathways and drug resistance mechanisms is essential to support the development of combination therapies. Overall, microbialderived compounds hold substantial potential in advancing precision oncology.
Authors
- Rajabrata Bhuyan (ORCID: https://orcid.org/0000-0001-7777-8230)
- Ekta Tyagi
- Divya Jain (ORCID: https://orcid.org/0000-0001-7220-5687)
- Anand Prakash (ORCID: https://orcid.org/0000-0002-9793-9182)
Institutions
- Banasthali University (IN)
- Uttaranchal University (IN)
Publication Details
- Journal
- Anti-Cancer Agents in Medicinal Chemistry
- Published
- 2025-09-04
- DOI
- https://doi.org/10.2174/0118715206399680250814104403
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00